Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Propranolol and Etodolac in Colorectal Cancer
NCT03919461Phase 2Recruiting
- Sponsor
- Shamir Medical Center
- Start
- Feb 2019
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol, etodolac in colorectal cancer (CRC), sponsored by Shamir Medical Center. Started Feb 2019; status: recruiting.
02
Drugs
propranololetodolac
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03919461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919461.